Items
Login
Register
Toggle Navigation
False Claims Act Enforcement
Quantity
Add to Cart
Back to Results
Recorded April 5, 2017 | On-Demand Webinar
Last year, the Supreme Court issued its opinion in Universal Health Services v. U.S. ex rel. Escobar, in which the Court affirmed the theory that violations of statutory and regulatory provisions can constitute actionable fraud under the False Claims Act (FCA). This webinar will explore different views on how this decision might affect FCA investigations and litigation in the coming years, including whether drug and device companies can expect more cases based on violations of provisions of the Federal Food, Drug & Cosmetic Act.
Jonathan M. Phillips, Associate Attorney, Gibson, Dunn & Crutcher LLP
Robert L. Vogel, Partner, Vogel, Slade & Goldstein LLP
IE and Edge users: Microsoft Internet Explorer (IE) and Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or
[email protected]
and we will assist you in your purchase.
Assign Members :
Members Assigned |
Assign all contacts
Unassign all contacts
View :
All
Assigned
Unassigned
Add New Contact
Add New Contact
Cancel
Save
Assign
Full Name
Account Name
Email
Role
Total Records
- Showing Page
Discounts and special pricing for additional items will be applied once you add the item to your cart.